Induction therapy pre‐autologous stem cell transplantation in immunoglobulin light chain amyloidosis: a retrospective evaluation

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-8652|91|10|984-988

ISSN： 0361-8609

Source： AMERICAN JOURNAL OF HEMATOLOGY, Vol.91, Iss.10, 2016-10, pp. : 984-988

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Autologous Stem Cell Transplantation in Multiple Myeloma in the Era of Novel Drug Induction: A Retrospective Single-Center Analysis

By  

Acta Haematologica, Vol. 137, Iss. 3, 2017-04 ,pp. : 163-172

Karger

Access to resources Recommend Favorite

Bortezomib‐thalidomide‐dexamethasone versus bortezomib‐cyclophosphamide‐dexamethasone as induction therapy prior to autologous stem cell transplantation in multiple myeloma

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 4, 2015-02 ,pp. : 605-606

John Wiley & Sons Inc

Access to resources Recommend Favorite

Thalidomide, Cyclophosphamide and Dexamethasone Induction Therapy: Feasibility for Myeloma Patients Destined for Autologous Stem Cell Transplantation

By  

Acta Haematologica, Vol. 132, Iss. 2, 2014-04 ,pp. : 226-232

Karger

Access to resources Recommend Favorite

Immunoglobulin Light-Chain Amyloidosis: From Basics to New Developments in Diagnosis, Prognosis and Therapy

By  

Acta Haematologica, Vol. 135, Iss. 3, 2016-01 ,pp. : 172-190

Karger

Access to resources Recommend Favorite

Characteristics and Long-Term Outcome of Patients with Systemic Immunoglobulin Light-Chain Amyloidosis

By  

Acta Haematologica, Vol. 133, Iss. 4, 2014-12 ,pp. : 336-346

Karger

Access to resources Recommend Favorite